3-50343153-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 2P and 17B. PM2BP4_StrongBP6_Very_StrongBP7BS1
The NM_015896.4(ZMYND10):āc.564C>Gā(p.Leu188Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000867 in 1,614,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00056 ( 0 hom., cov: 33)
Exomes š: 0.00090 ( 0 hom. )
Consequence
ZMYND10
NM_015896.4 synonymous
NM_015896.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.150
Genes affected
ZMYND10 (HGNC:19412): (zinc finger MYND-type containing 10) This gene encodes a protein containing a MYND-type zinc finger domain that likely functions in assembly of the dynein motor. Mutations in this gene can cause primary ciliary dyskinesia. This gene is also considered a tumor suppressor gene and is often mutated, deleted, or hypermethylated and silenced in cancer cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 3-50343153-G-C is Benign according to our data. Variant chr3-50343153-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 525470.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.15 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.000899 (1314/1461882) while in subpopulation NFE AF= 0.0011 (1218/1112002). AF 95% confidence interval is 0.00104. There are 0 homozygotes in gnomad4_exome. There are 623 alleles in male gnomad4_exome subpopulation. Median coverage is 33. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZMYND10 | NM_015896.4 | c.564C>G | p.Leu188Leu | synonymous_variant | 6/12 | ENST00000231749.8 | NP_056980.2 | |
ZMYND10 | NM_001308379.2 | c.564C>G | p.Leu188Leu | synonymous_variant | 6/11 | NP_001295308.1 | ||
ZMYND10 | XM_005265216.4 | c.327C>G | p.Leu109Leu | synonymous_variant | 5/11 | XP_005265273.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZMYND10 | ENST00000231749.8 | c.564C>G | p.Leu188Leu | synonymous_variant | 6/12 | 1 | NM_015896.4 | ENSP00000231749.3 |
Frequencies
GnomAD3 genomes AF: 0.000558 AC: 85AN: 152242Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
85
AN:
152242
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000545 AC: 137AN: 251414Hom.: 0 AF XY: 0.000522 AC XY: 71AN XY: 135890
GnomAD3 exomes
AF:
AC:
137
AN:
251414
Hom.:
AF XY:
AC XY:
71
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000899 AC: 1314AN: 1461882Hom.: 0 Cov.: 33 AF XY: 0.000857 AC XY: 623AN XY: 727246
GnomAD4 exome
AF:
AC:
1314
AN:
1461882
Hom.:
Cov.:
33
AF XY:
AC XY:
623
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000558 AC: 85AN: 152360Hom.: 0 Cov.: 33 AF XY: 0.000456 AC XY: 34AN XY: 74514
GnomAD4 genome
AF:
AC:
85
AN:
152360
Hom.:
Cov.:
33
AF XY:
AC XY:
34
AN XY:
74514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Primary ciliary dyskinesia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at